Zobrazeno 1 - 10
of 40
pro vyhledávání: '"microemulsion propofol"'
Publikováno v:
Korean Journal of Anesthesiology, Vol 62, Iss 4, Pp 358-364 (2012)
BackgroundLipid-emulsion propofol (LP) has cardioprotective effects against ischemia-reperfusion injury, but it has lipid-related side effects. Microemulsion propofol (MP) is a lipid-free propofol emulsified with 10% purified poloxamer 188 (PP188). P
Externí odkaz:
https://doaj.org/article/0f1d90503568407d839933d6947de41d
Publikováno v:
Korean Journal of Anesthesiology, Vol 60, Iss 2, Pp 83-89 (2011)
BackgroundPropofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol was developed to avoid these sid
Externí odkaz:
https://doaj.org/article/8fe7fd0cbd994155984962421ac2d71c
Publikováno v:
Korean Journal of Anesthesiology, Vol 60, Iss 2, Pp 78-82 (2011)
BackgroundThe injection pain of microemulsion propofol is frequent and difficult to prevent. This study examined the prevention of pain during microemulsion propofol injection by pretreatment with different doses of remifentanil or saline, and premix
Externí odkaz:
https://doaj.org/article/af273e63270a4b3f92eb05ed28d20f30
Autor:
Hyun-Sik Kim, Kwang Rae Cho, Jeong Han Lee, Young Hwan Kim, Se Hun Lim, Kun Moo Lee, Soon Ho Cheong, Young Jae Kim, Chee-Mahn Shin, Jin-Young Lee
Publikováno v:
Korean Journal of Anesthesiology, Vol 59, Iss 5, Pp 310-313 (2010)
BackgroundSimilar to lipid emulsion propofol, microemulsion propofol also causes a high incidence of pain during intravenous injection. Various methods have been used to minimize the incidence and severity of pain on injection of lipid emulsion propo
Externí odkaz:
https://doaj.org/article/b6bdd9ba207742ab8bec3939a258ad5a
Publikováno v:
Korean Journal of Anesthesiology, Vol 58, Iss 5, Pp 435-439 (2010)
BackgroundMicroemulsion propofol produces more frequent and severe pain upon injection than lipid emulsion propofol. This study examined the analgesic effect of lidocaine-premixed microemulsion propofol in patients pretreated with remifentanil. The i
Externí odkaz:
https://doaj.org/article/842b670feb1a4ca59b2b021060f4d924
Publikováno v:
Korean Journal of Anesthesiology
Korean Journal of Anesthesiology, Vol 60, Iss 2, Pp 83-89 (2011)
Korean Journal of Anesthesiology, Vol 60, Iss 2, Pp 83-89 (2011)
Background Propofol is used as an induction and maintenance agent for general anesthesia but it can cause adverse reactions like hyperlipidemia, growth of microorganisms, and pulmonary embolisms. Microemulsion propofol was developed to avoid these si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d159d4ee7087d5c98d92425b7a0b8a8
https://pubmed.ncbi.nlm.nih.gov/21390162
https://pubmed.ncbi.nlm.nih.gov/21390162
Publikováno v:
Korean Journal of Anesthesiology
Korean Journal of Anesthesiology, Vol 58, Iss 5, Pp 435-439 (2010)
Korean Journal of Anesthesiology, Vol 58, Iss 5, Pp 435-439 (2010)
Background: Microemulsion propofol produces more frequent and severe pain upon injection than lipid emulsion propofol. This study examined the analgesic effect of lidocaine-premixed microemulsion propofol in patients pretreated with remifentanil. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c702cdf13ae2ad51708eb6ed41b4042
https://pubmed.ncbi.nlm.nih.gov/20532050
https://pubmed.ncbi.nlm.nih.gov/20532050
Publikováno v:
Korean Journal of Anesthesiology
Korean Journal of Anesthesiology, Vol 62, Iss 4, Pp 358-364 (2012)
Korean Journal of Anesthesiology, Vol 62, Iss 4, Pp 358-364 (2012)
Background Lipid-emulsion propofol (LP) has cardioprotective effects against ischemia-reperfusion injury, but it has lipid-related side effects. Microemulsion propofol (MP) is a lipid-free propofol emulsified with 10% purified poloxamer 188 (PP188).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0909ce4b312135bf70e344d5363f2df
https://doi.org/10.4097/kjae.2012.62.4.358
https://doi.org/10.4097/kjae.2012.62.4.358
Autor:
Soon Im Kim, Sun Young Park, Sang Ho Kim, Su Myung Lee, Si Young Ok, Se Jin Lee, Bo Il Jung, Mun Gyu Kim
Publikováno v:
Journal of Korean Medical Science
Although rare, intraoperative anaphylaxis can lead to significant morbidity and mortality. Aquafol® (Daewon Pharmaceutical Co. Ltd., Seoul, Korea), a microemulsion propofol, was developed to eliminate lipid solvent-related adverse events, and was us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ba7b8e3e308515efaf3b2d1ee49b4d
https://doi.org/10.3346/jkms.2012.27.7.827
https://doi.org/10.3346/jkms.2012.27.7.827
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.